Medicine & Pharmaceuticals

Latest News Releases

*DISCLAIMER*: Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.

HeadlinesMore>>
Kite Pharma's Lead Program with the National Cancer Institute (NCI) Demonstrates Positive Results in Patients with Aggressive Non-Hodgkin's Lymphoma
Kite Pharma's Lead Program with the National Cancer Institute (NCI) Demonstrates Positive Results in Patients with Aggressive Non-Hodgkin's Lymphoma
Kite Pharma, Inc. (Kite), a clinical-stage biotechnology company focused on engineered autologous T cell therapy (eACT) products for cancer, today announced positive clinical data demonstrating that Kite's most...More >>
Kite Pharma, Inc. (Kite), a clinical-stage biotechnology company focused on engineered autologous T cell therapy (eACT) products for cancer, today announced positive clinical data demonstrating that Kite's most...More >>
Synthetic Biologics Enters into License with Cedars-Sinai Medical Center to Develop Novel Anti-infective Approaches for Irritable Bowel Syndrome (IBS), Obesity and Diabetes
Synthetic Biologics Enters into License with Cedars-Sinai Medical Center to Develop Novel Anti-infective Approaches for Irritable Bowel Syndrome (IBS), Obesity and Diabetes
Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of product candidates focused on the prevention and treatment of serious infectious diseases and other diseases, announced today that it entered into worldwide license...More >>
Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of product candidates focused on the prevention and treatment of serious infectious diseases and other diseases, announced today that it entered into worldwide license...More >>
NKT Therapeutics Reports First Clinical Results with anti-iNKT Antibody in Patients with Sickle Cell Disease
NKT Therapeutics Reports First Clinical Results with anti-iNKT Antibody in Patients with Sickle Cell Disease
NKT Therapeutics today announced the presentation of initial clinical results with NKTT120, a monoclonal antibody designed to suppress the chronic inflammation associated with sickle cell disease (SCD) pathology. Interim...More >>
NKT Therapeutics today announced the presentation of initial clinical results with NKTT120, a monoclonal antibody designed to suppress the chronic inflammation associated with sickle cell disease (SCD) pathology. Interim...More >>
Penn Medicine Team Reports Findings from Research Study of First 59 Adult and Pediatric Leukemia Patients Who Received Investigational, Personalized Cellular Therapy CTL019
Penn Medicine Team Reports Findings from Research Study of First 59 Adult and Pediatric Leukemia Patients Who Received Investigational, Personalized Cellular Therapy CTL019
Three and a half years after beginning a clinical trial which demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team from the Perelman School of Medicine at...More >>
Three and a half years after beginning a clinical trial which demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team from the Perelman School of Medicine at...More >>
Novartis highlights research on investigational, personalized T cell therapy CTL019 in patients with forms of acute and chronic leukemia
Novartis highlights research on investigational, personalized T cell therapy CTL019 in patients with forms of acute and chronic leukemia
Novartis is highlighting new research from members of the faculty at the University of Pennsylvania's Perelman School of Medicine (Penn) on the investigational chimeric antigen receptor (CAR) therapy, CTL019. Several...More >>
Novartis is highlighting new research from members of the faculty at the University of Pennsylvania's Perelman School of Medicine (Penn) on the investigational chimeric antigen receptor (CAR) therapy, CTL019. Several...More >>
Research Study of T Cell Immunotherapy Continues to Show Highly Promising Results in Children and Adults with Leukemia
Research Study of T Cell Immunotherapy Continues to Show Highly Promising Results in Children and Adults with Leukemia
Nearly 90 percent of children and adults with a highly aggressive form of acute lymphoblastic leukemia (ALL) showed no evidence of cancer after receiving a novel, personalized cell therapy that reprograms a patient's...More >>
Nearly 90 percent of children and adults with a highly aggressive form of acute lymphoblastic leukemia (ALL) showed no evidence of cancer after receiving a novel, personalized cell therapy that reprograms a patient's...More >>
Cardiac Designs™ to exhibit ECG Check at 5th Annual mHealth Summit in Washington, DC
Cardiac Designs™ to exhibit ECG Check at 5th Annual mHealth Summit in Washington, DC
Cardiac Designs Inc. announced today that its ECG Check mobile heart monitor and analysis engine for iPhone 5 & 5S will be showcased at the 5th Annual mHealth Summit in Washington, D.C., December 8-11, 2013 in Booth...More >>
Cardiac Designs Inc. announced today that its ECG Check mobile heart monitor and analysis engine for iPhone 5 & 5S will be showcased at the 5th Annual mHealth Summit in Washington, D.C., December 8-11, 2013 in Booth...More >>
Nora Therapeutics Announces New Time for Presentation at the Oppenheimer 24th Annual Healthcare Conference
Nora Therapeutics Announces New Time for Presentation at the Oppenheimer 24th Annual Healthcare Conference
Nora Therapeutics announced today that CEO Jeffrey K. Tong, Ph.D., will present at the Oppenheimer 24th Annual Healthcare Conference. The conference will take place Dec. 10 – 11 at the Crowne Plaza Hotel in New York City.More >>
Nora Therapeutics announced today that CEO Jeffrey K. Tong, Ph.D., will present at the Oppenheimer 24th Annual Healthcare Conference. The conference will take place Dec. 10 – 11 at the Crowne Plaza Hotel in New York City.More >>
ThromboGenics' Founder Prof Desire Collen Retiring as Chairman
ThromboGenics' Founder Prof Desire Collen Retiring as Chairman
Dr Staf Van Reet appointed as new Chairman of the Board ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines,...More >>
Dr Staf Van Reet appointed as new Chairman of the Board ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines,...More >>
Consumer Health Call Centers Exploring & Modernizing Technologies to Expand Customer Connectivity
Consumer Health Call Centers Exploring & Modernizing Technologies to Expand Customer Connectivity
Call centers today are increasingly faced with various pressures, including meeting regulatory requirements and satisfying customer inquiries. In addition, leaders must effectively complete these tasks while also holding...More >>
Call centers today are increasingly faced with various pressures, including meeting regulatory requirements and satisfying customer inquiries. In addition, leaders must effectively complete these tasks while also holding...More >>
Arteriocyte Medical Systems, Inc. applauds CMS for adding Magellan® Bio-Bandage™ as an option for Medicare and Medicaid Patients with chronic wounds
Arteriocyte Medical Systems, Inc. applauds CMS for adding Magellan® Bio-Bandage™ as an option for Medicare and Medicaid Patients with chronic wounds
Arteriocyte Medical Systems, Inc., a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts, announced today that the Centers for Medicare and Medicaid Services (CMS) has issued final...More >>
Arteriocyte Medical Systems, Inc., a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts, announced today that the Centers for Medicare and Medicaid Services (CMS) has issued final...More >>
Shanghai Ajinomoto Amino Acid Co., Ltd. Expands Amino Acid Production Capacity
Shanghai Ajinomoto Amino Acid Co., Ltd. Expands Amino Acid Production Capacity
Ajinomoto Co., Inc. (Ajinomoto Co.) has announced that its subsidiary, Shanghai Ajinomoto Amino Acid Co., Ltd. in Shanghai, China, has begun operation of its newly expanded amino acid production line. The expansion for the...More >>
Ajinomoto Co., Inc. (Ajinomoto Co.) has announced that its subsidiary, Shanghai Ajinomoto Amino Acid Co., Ltd. in Shanghai, China, has begun operation of its newly expanded amino acid production line. The expansion for the...More >>
Regado Biosciences, Inc. to Present at Oppenheimer's 24th Annual Healthcare Conference
Regado Biosciences, Inc. to Present at Oppenheimer's 24th Annual Healthcare Conference
Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced it will...More >>
Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced it will...More >>
NASA, CASIS Make Space Station Accessible for Stem Cell Research
NASA, CASIS Make Space Station Accessible for Stem Cell Research
NASA and the Center for the Advancement of Science in Space (CASIS) are enabling research aboard the International Space Station that could lead to new stem cell-based therapies for medical conditions faced on Earth and in...More >>
NASA and the Center for the Advancement of Science in Space (CASIS) are enabling research aboard the International Space Station that could lead to new stem cell-based therapies for medical conditions faced on Earth and in...More >>
BioSpecifics Technologies Corp. Announces FDA Approval of XIAFLEX® for the Treatment of Peyronie's Disease
BioSpecifics Technologies Corp. Announces FDA Approval of XIAFLEX® for the Treatment of Peyronie's Disease
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S and XIAPEX® in...More >>
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S and XIAPEX® in...More >>
Ensuring Critical Leadership Messages are Effectively Communicated Across an Organization
Ensuring Critical Leadership Messages are Effectively Communicated Across an Organization
Organizations across all industries need effective internal communication practices to ensure that critical leadership messages around products, strategy and goals are successfully conveyed to employees. In many companies,...More >>
Organizations across all industries need effective internal communication practices to ensure that critical leadership messages around products, strategy and goals are successfully conveyed to employees. In many companies,...More >>
Pharmapack North America Issues a Call for Papers
Pharmapack North America Issues a Call for Papers
Organizers of Pharmapack North America have announced a "Call for Papers" for the third annual conference scheduled to be held at the Jacob K. Javits Convention Center in New York City, June 10-11. UBM Canon and PMP News...More >>
Organizers of Pharmapack North America have announced a "Call for Papers" for the third annual conference scheduled to be held at the Jacob K. Javits Convention Center in New York City, June 10-11. UBM Canon and PMP News...More >>
Web site Gives Patients New Insight into Oral and Maxillofacial Surgery
Web site Gives Patients New Insight into Oral and Maxillofacial Surgery
The American Association of Oral and Maxillofacial Surgeons (AAOMS) unveiled a new Web site this week, allowing the public to more easily access vital information about conditions of the face, mouth and jaw and their...More >>
The American Association of Oral and Maxillofacial Surgeons (AAOMS) unveiled a new Web site this week, allowing the public to more easily access vital information about conditions of the face, mouth and jaw and their...More >>
C4 Imaging Announces FDA 510(k) Clearance of its Positive-Signal MRI Marker - Sirius™
C4 Imaging Announces FDA 510(k) Clearance of its Positive-Signal MRI Marker - Sirius™
C4 Imaging LLC is pleased to announce U.S. Food and Drug Administration 510(k) clearance of its first product, the Sirius™ MRI Marker. The novel Positive-Signal MRI Marker will be used following treatment of prostate...More >>
C4 Imaging LLC is pleased to announce U.S. Food and Drug Administration 510(k) clearance of its first product, the Sirius™ MRI Marker. The novel Positive-Signal MRI Marker will be used following treatment of prostate...More >>
Assured Pharmacy, Inc. Announces Extension of Issuer Tender Offer
Assured Pharmacy, Inc. Announces Extension of Issuer Tender Offer
Assured Pharmacy, Inc. (OTCQB: APHY), today announced that it has extended the expiration of its previously announced tender offer to exchange 16% Senior Convertible Debentures (the "Eligible Debentures") and warrants to...More >>
Assured Pharmacy, Inc. (OTCQB: APHY), today announced that it has extended the expiration of its previously announced tender offer to exchange 16% Senior Convertible Debentures (the "Eligible Debentures") and warrants to...More >>
Boston Therapeutics, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Boston Therapeutics, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Boston Therapeutics, Inc. (OTCQB: BTHE) today announced its December 5th RetailInvestorConferences.com presentation is now available for on-demand viewing.More >>
Boston Therapeutics, Inc. (OTCQB: BTHE) today announced its December 5th RetailInvestorConferences.com presentation is now available for on-demand viewing.More >>
China Human Vaccine Industry Report 2013
China Human Vaccine Industry Report 2013
Research and Markets (http://www.researchandmarkets.com/research/srtkcw/china_human) has announced the addition of the "China Human Vaccine Industry Report 2013" report to their offering.More >>
Research and Markets (http://www.researchandmarkets.com/research/srtkcw/china_human) has announced the addition of the "China Human Vaccine Industry Report 2013" report to their offering.More >>
Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX® for the Treatment of Peyronie's Disease
Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX® for the Treatment of Peyronie's Disease
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved XIAFLEX® (collagenase clostridium...More >>
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved XIAFLEX® (collagenase clostridium...More >>
ATS Labs Expands to Offer Full Analytical Chemistry Testing Services
ATS Labs Expands to Offer Full Analytical Chemistry Testing Services
ATS Labs, a leading provider of microbiology and virology efficacy testing services to the regulated antimicrobial industry, today announces the launch of its new analytical chemistry testing services. ATS Labs is now...More >>
ATS Labs, a leading provider of microbiology and virology efficacy testing services to the regulated antimicrobial industry, today announces the launch of its new analytical chemistry testing services. ATS Labs is now...More >>
ATS Labs Offers Antimicrobial Testing Utilizing Avian Influenza A (H7N9) Virus
ATS Labs Offers Antimicrobial Testing Utilizing Avian Influenza A (H7N9) Virus
ATS Labs announced today that they are pleased to offer testing of antimicrobial products for efficacy against avian influenza A (H7N9) virus. Avian influenza A (H7N9) virus, called H7N9 for short, has infected humans in...More >>
ATS Labs announced today that they are pleased to offer testing of antimicrobial products for efficacy against avian influenza A (H7N9) virus. Avian influenza A (H7N9) virus, called H7N9 for short, has infected humans in...More >>
Operating Tables - Global Strategic Business Report
Operating Tables - Global Strategic Business Report
Research and Markets (http://www.researchandmarkets.com/research/rr4qfd/operating_tables) has announced the addition of the "Operating Tables - Global Strategic Business Report" report to their offering. (Logo:...More >>
Research and Markets (http://www.researchandmarkets.com/research/rr4qfd/operating_tables) has announced the addition of the "Operating Tables - Global Strategic Business Report" report to their offering. (Logo:...More >>
Addus HomeCare Announces the closing of its previously announced purchase of fifteen offices in New Mexico
Addus HomeCare Announces the closing of its previously announced purchase of fifteen offices in New Mexico
Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home-based social and medical services focused on the elderly dual eligible population, announced today that the Company closed on its acquisition of the previously...More >>
Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home-based social and medical services focused on the elderly dual eligible population, announced today that the Company closed on its acquisition of the previously...More >>
EEG/EMG/Brain Function Monitoring - Global Strategic Business Report
EEG/EMG/Brain Function Monitoring - Global Strategic Business Report
Research and Markets ( http://www.researchandmarkets.com/research/q42m9v/eegemgbrain) has announced the addition of the "EEG/EMG/Brain Function Monitoring - Global Strategic Business Report" report to their offering. ...More >>
Research and Markets ( http://www.researchandmarkets.com/research/q42m9v/eegemgbrain) has announced the addition of the "EEG/EMG/Brain Function Monitoring - Global Strategic Business Report" report to their offering. ...More >>
Xencor, Inc. Announces Closing of Initial Public Offering
Xencor, Inc. Announces Closing of Initial Public Offering
Xencor, Inc. (NASDAQ: XNCR) today announced the closing of its initial public offering of 14,639,500 shares of its common stock at an initial public offering price of $5.50 per share, which includes the exercise in full by...More >>
Xencor, Inc. (NASDAQ: XNCR) today announced the closing of its initial public offering of 14,639,500 shares of its common stock at an initial public offering price of $5.50 per share, which includes the exercise in full by...More >>
Global Intraocular Lenses Report 2013-2018: Technological Innovations - A Boon to the IOL Industry
Global Intraocular Lenses Report 2013-2018: Technological Innovations - A Boon to the IOL Industry
Research and Markets (http://www.researchandmarkets.com/research/mkcr2d/intraocular) has announced the addition of the "Global Intraocular Lenses Report 2013-2018" report to their offering. (Logo:...More >>
Research and Markets (http://www.researchandmarkets.com/research/mkcr2d/intraocular) has announced the addition of the "Global Intraocular Lenses Report 2013-2018" report to their offering. (Logo:...More >>
CVS Caremark To Host 2013 Analyst Day For The Investment Community
CVS Caremark To Host 2013 Analyst Day For The Investment Community
CVS Caremark Corporation (NYSE: CVS) will hold its annual Analyst Day in New York City on Wednesday, December 18, 2013, beginning at 8:00 a.m. (ET). Senior members of the CVS Caremark leadership team will provide an...More >>
CVS Caremark Corporation (NYSE: CVS) will hold its annual Analyst Day in New York City on Wednesday, December 18, 2013, beginning at 8:00 a.m. (ET). Senior members of the CVS Caremark leadership team will provide an...More >>
As Mirena IUD Lawsuits Mount, Bernstein Liebhard LLP Comments on Recent Media Report Detailing Alleged Mirena Complications
As Mirena IUD Lawsuits Mount, Bernstein Liebhard LLP Comments on Recent Media Report Detailing Alleged Mirena Complications
As Mirena IUD lawsuits (http://www.mirenalawsuitclaims.com/ ) continue to make their way through courts around the country, a new media report is shedding light on the types of injuries plaintiffs in these claims have...More >>
As Mirena IUD lawsuits (http://www.mirenalawsuitclaims.com/ ) continue to make their way through courts around the country, a new media report is shedding light on the types of injuries plaintiffs in these claims have...More >>
Huntsville Hospital Health System Selects Caradigm® Health Information Exchange as Backbone for Integrated Care in Northern Alabama
Huntsville Hospital Health System Selects Caradigm® Health Information Exchange as Backbone for Integrated Care in Northern Alabama
Huntsville Hospital Health System, the nation's fifth largest publicly owned healthcare organization, has selected the Caradigm Health Information Exchange (HIE), powered by Orion Health, to provide the backbone for...More >>
Huntsville Hospital Health System, the nation's fifth largest publicly owned healthcare organization, has selected the Caradigm Health Information Exchange (HIE), powered by Orion Health, to provide the backbone for...More >>
Orexigen Therapeutics, Inc. Announces the Closing of its Offering of $115 Million of Convertible Senior Notes
Orexigen Therapeutics, Inc. Announces the Closing of its Offering of $115 Million of Convertible Senior Notes
Orexigen® Therapeutics, Inc. (Nasdaq: OREX) (the "Company"), a biopharmaceutical company focused on the treatment of obesity, today announced the closing of its offering of $115 million aggregate principal amount of...More >>
Orexigen® Therapeutics, Inc. (Nasdaq: OREX) (the "Company"), a biopharmaceutical company focused on the treatment of obesity, today announced the closing of its offering of $115 million aggregate principal amount of...More >>
TRI Contributes to a National Cancer Institute Study for Cancer Treatment
TRI Contributes to a National Cancer Institute Study for Cancer Treatment
TRI's Data Management and Biostatistics staff contributed to a study on the response to cancer therapy of an intact population of microorganisms living in the intestine. The study was a collaborative effort with...More >>
TRI's Data Management and Biostatistics staff contributed to a study on the response to cancer therapy of an intact population of microorganisms living in the intestine. The study was a collaborative effort with...More >>
Boston Scientific Reports Favorable Results Assessing Real-World Experience with the Precision Spectra™ Spinal Cord Stimulator System
Boston Scientific Reports Favorable Results Assessing Real-World Experience with the Precision Spectra™ Spinal Cord Stimulator System
New retrospective data highlighting the Boston Scientific Corporation (NYSE: BSX) Precision Spectra™ Spinal Cord Stimulator (SCS) System demonstrate the device provided highly significant pain relief three months after...More >>
New retrospective data highlighting the Boston Scientific Corporation (NYSE: BSX) Precision Spectra™ Spinal Cord Stimulator (SCS) System demonstrate the device provided highly significant pain relief three months after...More >>
Los Angeles Optometrist, Dr. Ramin Rabbani, is Now Offering iVitamins
Los Angeles Optometrist, Dr. Ramin Rabbani, is Now Offering iVitamins
Los Angeles optometrist, Dr. Ramin Rabbani, is now offering iVitamins, which can help patients achieve optimal eye health. Ocular nutritional therapy combines leading-edge technology with natural supplements to create...More >>
Los Angeles optometrist, Dr. Ramin Rabbani, is now offering iVitamins, which can help patients achieve optimal eye health. Ocular nutritional therapy combines leading-edge technology with natural supplements to create...More >>
HeartWare Presentation At The Oppenheimer 24th Annual Healthcare Conference To Be Webcast
HeartWare Presentation At The Oppenheimer 24th Annual Healthcare Conference To Be Webcast
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO...More >>
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO...More >>
Healing Wounds: The Dressing Makes the Deciding Difference
Healing Wounds: The Dressing Makes the Deciding Difference
Surgical procedures have come a long way, thanks to technological advancements and better-trained surgeons. This means that superior results can be expected even in high-risk surgeries. However, surgery is one thing;...More >>
Surgical procedures have come a long way, thanks to technological advancements and better-trained surgeons. This means that superior results can be expected even in high-risk surgeries. However, surgery is one thing;...More >>
Osseon Announces New Regional Sales Director
Osseon Announces New Regional Sales Director
Osseon Therapeutics, Inc. is pleased to announce that Gary Hogman has joined the company as the latest member of its Sales Management team. Mr. Hogman's expertise in the Spine and Vertebral Compression Fracture arena...More >>
Osseon Therapeutics, Inc. is pleased to announce that Gary Hogman has joined the company as the latest member of its Sales Management team. Mr. Hogman's expertise in the Spine and Vertebral Compression Fracture arena...More >>
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ambit Biosciences Corporation
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ambit Biosciences Corporation
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Ambit Biosciences Corporation. ("Ambit" or the "Company") (NasdaqGM: AMBI). ...More >>
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Ambit Biosciences Corporation. ("Ambit" or the "Company") (NasdaqGM: AMBI). ...More >>
Concord Medical Announces the Closing of Acquisition of Its Shares by CEO and COO from Other Shareholders
Concord Medical Announces the Closing of Acquisition of Its Shares by CEO and COO from Other Shareholders
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic...More >>
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic...More >>
Cardinal Health Launches New Service To Help Hospitals Expand Reach Of Their Outpatient Pharmacies
Cardinal Health Launches New Service To Help Hospitals Expand Reach Of Their Outpatient Pharmacies
At the annual Midyear Clinical Meeting of the American Society of Health-System Pharmacists (ASHP), Cardinal Health will launch a new service that helps hospitals and integrated delivery networks expand the reach of their...More >>
At the annual Midyear Clinical Meeting of the American Society of Health-System Pharmacists (ASHP), Cardinal Health will launch a new service that helps hospitals and integrated delivery networks expand the reach of their...More >>
ALS Therapy Development Institute and Neurimmune Partner to Advance Treatments for ALS
ALS Therapy Development Institute and Neurimmune Partner to Advance Treatments for ALS
The ALS Therapy Development Institute (ALS TDI), together with its wholly-owned subsidiary, Anelixis Therapeutics, announced today that it has formed a research partnership with Neurimmune to advance potential treatments...More >>
The ALS Therapy Development Institute (ALS TDI), together with its wholly-owned subsidiary, Anelixis Therapeutics, announced today that it has formed a research partnership with Neurimmune to advance potential treatments...More >>
Sangamo BioSciences Presents Clinical Data From Key SB-728-T HIV Studies: Proof Of Concept For Ongoing Sustained Functional Control Of HIV Viral Load; Cytoxan Preconditioning Successfully Enhances Engraftment
Sangamo BioSciences Presents Clinical Data From Key SB-728-T HIV Studies: Proof Of Concept For Ongoing Sustained Functional Control Of HIV Viral Load; Cytoxan Preconditioning Successfully Enhances Engraftment
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the presentation of data from all dose cohorts in the Company's ongoing clinical trials (SB-728-1101 and SB-728-902 Cohort 5) of SB-728-T, which is being...More >>
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the presentation of data from all dose cohorts in the Company's ongoing clinical trials (SB-728-1101 and SB-728-902 Cohort 5) of SB-728-T, which is being...More >>
Boston Scientific and The Medicines Company Announce U.S. Co-Promotion Agreement for Promus PREMIER™ Stent System
Boston Scientific and The Medicines Company Announce U.S. Co-Promotion Agreement for Promus PREMIER™ Stent System
Boston Scientific Corporation (NYSE: BSX) and The Medicines Company (NASDAQ: MDCO) announce a co-promotion agreement for the Boston Scientific Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary Stent System. ...More >>
Boston Scientific Corporation (NYSE: BSX) and The Medicines Company (NASDAQ: MDCO) announce a co-promotion agreement for the Boston Scientific Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary Stent System. ...More >>
Cancer Vaccine Partnering Terms and Agreements
Cancer Vaccine Partnering Terms and Agreements
Reportlinker.com announces that a new market research report is available in its catalogue:More >>
Bharat Book Bureau presents Cancer Vaccine Partnering Terms and Agreements. This report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the world's leading...More >>
Biocartis and VIB Join Forces to Develop Unique Diagnostic Cancer Test
Biocartis and VIB Join Forces to Develop Unique Diagnostic Cancer Test
Today Biocartis and VIB announced their exclusive license agreement on a novel panel of microsatellite instability (MSI) biomarkers for several cancers, in particular colorectal cancer (CRC). This agreement will enable...More >>
Today Biocartis and VIB announced their exclusive license agreement on a novel panel of microsatellite instability (MSI) biomarkers for several cancers, in particular colorectal cancer (CRC). This agreement will enable...More >>
Bavarian Nordic, the international novel cancer and infectious disease vaccines focused biotech, now covered by Edison.
Bavarian Nordic, the international novel cancer and infectious disease vaccines focused biotech, now covered by Edison.
Edison Investment Research's report, An intriguing PROSPECT, examines the long-term investment case for Bavarian Nordic, which rests on key value driver Prostvac, its Phase III prostate cancer vaccine.More >>
Edison Investment Research's report, An intriguing PROSPECT, examines the long-term investment case for Bavarian Nordic, which rests on key value driver Prostvac, its Phase III prostate cancer vaccine.More >>
Nutranomics Appoints MD and PhD Microbiologist as Supply Chain Manager
Nutranomics Appoints MD and PhD Microbiologist as Supply Chain Manager
Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to report that it has appointed Enkhmart (Michelle) Dudleenamjil, MD, Ph.D., to the position of Supply Chain Manager.More >>
Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to report that it has appointed Enkhmart (Michelle) Dudleenamjil, MD, Ph.D., to the position of Supply Chain Manager.More >>
New White Paper from Tuberous Sclerosis Alliance Assesses Visual Field Risks of Vigabatrin
New White Paper from Tuberous Sclerosis Alliance Assesses Visual Field Risks of Vigabatrin
A new white paper from the Tuberous Sclerosis Alliance (TS Alliance), entitled "Vigabatrin-Associated Visual Field Loss (VAVFL): What You Need to Know," was released today at the American Epilepsy Society annual meeting in...More >>
A new white paper from the Tuberous Sclerosis Alliance (TS Alliance), entitled "Vigabatrin-Associated Visual Field Loss (VAVFL): What You Need to Know," was released today at the American Epilepsy Society annual meeting in...More >>
UPCOMING DEADLINE: Levi & Korsinsky, LLP Announces Class Action Against ARIAD Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ARIA
UPCOMING DEADLINE: Levi & Korsinsky, LLP Announces Class Action Against ARIAD Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ARIA
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who purchased ARIAD Pharmaceuticals, Inc. ("ARIAD"...More >>
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who purchased ARIAD Pharmaceuticals, Inc. ("ARIAD"...More >>
Questcor Pharmaceuticals to Present at the Oppenheimer Annual Healthcare Conference
Questcor Pharmaceuticals to Present at the Oppenheimer Annual Healthcare Conference
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Oppenheimer 24th Annual Healthcare Conference in New York City on December 11, 2013 at 8:20 AM ET/5:20 AM PT.More >>
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Oppenheimer 24th Annual Healthcare Conference in New York City on December 11, 2013 at 8:20 AM ET/5:20 AM PT.More >>
Shire Reports Top-Line Results on OPUS-2, a Phase 3 Study Investigating the Use of Lifitegrast (5.0% Ophthalmic Solution) in Adults With Dry Eye Disease
Shire Reports Top-Line Results on OPUS-2, a Phase 3 Study Investigating the Use of Lifitegrast (5.0% Ophthalmic Solution) in Adults With Dry Eye Disease
Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, today announced top-line results from OPUS-2, a Phase 3 efficacy and safety study of 5.0% lifitegrast ophthalmic solution. OPUS-2 compared...More >>
Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, today announced top-line results from OPUS-2, a Phase 3 efficacy and safety study of 5.0% lifitegrast ophthalmic solution. OPUS-2 compared...More >>
KaloBios Receives Notice of Allowance for Key Composition of Matter Patent Covering KBOO4
KaloBios Receives Notice of Allowance for Key Composition of Matter Patent Covering KBOO4
KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a composition of matter patent covering certain antibodies targeting EphA3,...More >>
KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a composition of matter patent covering certain antibodies targeting EphA3,...More >>
High-Powered Handheld Blue Laser Toys Can Cause Serious Eye Injuries
High-Powered Handheld Blue Laser Toys Can Cause Serious Eye Injuries
Exposure for even fractions of a second to high-powered blue handheld laser devices can cause serious eye injuries, according to a study[1] recently released online in Ophthalmology, the journal of the American Academy of...More >>
Exposure for even fractions of a second to high-powered blue handheld laser devices can cause serious eye injuries, according to a study[1] recently released online in Ophthalmology, the journal of the American Academy of...More >>
American Pacific To Release Financial Results And Hold Fiscal 2013 Year-End And Fourth Quarter Investor Teleconference
American Pacific To Release Financial Results And Hold Fiscal 2013 Year-End And Fourth Quarter Investor Teleconference
American Pacific Corporation (NASDAQ: APFC) ("AMPAC") announced today that it will release its Fiscal 2013 year-end and fourth quarter financial results on Thursday, December 12, 2013, immediately after the stock market...More >>
American Pacific Corporation (NASDAQ: APFC) ("AMPAC") announced today that it will release its Fiscal 2013 year-end and fourth quarter financial results on Thursday, December 12, 2013, immediately after the stock market...More >>
Auxilium Pharmaceuticals, Inc. To Present At The Oppenheimer Conference
Auxilium Pharmaceuticals, Inc. To Present At The Oppenheimer Conference
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that executive management will participate in the Oppenheimer 24th Annual Conference to be held December 10-11, 2013 at the Crown Plaza in New York. Mr. Adrian...More >>
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that executive management will participate in the Oppenheimer 24th Annual Conference to be held December 10-11, 2013 at the Crown Plaza in New York. Mr. Adrian...More >>
Lilly Releases Report on Corporate Responsibility Efforts
Lilly Releases Report on Corporate Responsibility Efforts
Eli Lilly and Company (NYSE: LLY) has released its 2012-13 Corporate Responsibility Report. The report offers a comprehensive look at the company's progress on numerous corporate responsibility goals and efforts,...More >>
Eli Lilly and Company (NYSE: LLY) has released its 2012-13 Corporate Responsibility Report. The report offers a comprehensive look at the company's progress on numerous corporate responsibility goals and efforts,...More >>
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ambit Biosciences Corporation. - AMBI
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ambit Biosciences Corporation. - AMBI
Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Ambit Biosciences Corporation ("Ambit" or the "Company")(NASDAQ: AMBI). Such investors are advised to contact Robert...More >>
Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Ambit Biosciences Corporation ("Ambit" or the "Company")(NASDAQ: AMBI). Such investors are advised to contact Robert...More >>
Prime Therapeutics executives discuss customer experience, consumerism and reform at major health conferences
Prime Therapeutics executives discuss customer experience, consumerism and reform at major health conferences
This week, attendees at two leading health care conferences heard from top customer experience and marketing leaders of Prime Therapeutics LLC (Prime). Ingrid Lindberg, chief customer experience officer, gave a keynote...More >>
This week, attendees at two leading health care conferences heard from top customer experience and marketing leaders of Prime Therapeutics LLC (Prime). Ingrid Lindberg, chief customer experience officer, gave a keynote...More >>
Amgen To Present At The Oppenheimer 24th Annual Healthcare Conference
Amgen To Present At The Oppenheimer 24th Annual Healthcare Conference
Amgen (NASDAQ:AMGN) will participate at the Oppenheimer 24th Annual Healthcare Conference on Tuesday, Dec. 10, 2013, at the Crowne Plaza in New York City, beginning at 9:45 a.m. Eastern Standard Time. Arvind Sood, vice...More >>
Amgen (NASDAQ:AMGN) will participate at the Oppenheimer 24th Annual Healthcare Conference on Tuesday, Dec. 10, 2013, at the Crowne Plaza in New York City, beginning at 9:45 a.m. Eastern Standard Time. Arvind Sood, vice...More >>
Scleroderma May Be Initiated By Cancer
Scleroderma May Be Initiated By Cancer
The Scleroderma Research Foundation today reported that researchers at The Johns Hopkins University have discovered that some cases of scleroderma are likely to have been initiated by cancer. In a landmark paper published...More >>
The Scleroderma Research Foundation today reported that researchers at The Johns Hopkins University have discovered that some cases of scleroderma are likely to have been initiated by cancer. In a landmark paper published...More >>
New 2 Hour Educational Learning Labs Will be Unveiled at Design, Engineering and Manufacturing Event in Anaheim
New 2 Hour Educational Learning Labs Will be Unveiled at Design, Engineering and Manufacturing Event in Anaheim
UBM Canon is pleased to announce its new series of educational Learning Labs that appeal to expo attendees across all seven co-located industry shows. The Learning Labs will focus on applying critical concepts and enabling...More >>
UBM Canon is pleased to announce its new series of educational Learning Labs that appeal to expo attendees across all seven co-located industry shows. The Learning Labs will focus on applying critical concepts and enabling...More >>
Nurse-Led Innovations Demonstrate Improved Patient Outcomes, Bottom-Line Impact
Nurse-Led Innovations Demonstrate Improved Patient Outcomes, Bottom-Line Impact
Nurse-led initiatives in Indiana measurably improved patient outcomes while demonstrating anticipated financial savings of more than $5.2 million to their organizations, according to initial results from a hospital-based...More >>
Nurse-led initiatives in Indiana measurably improved patient outcomes while demonstrating anticipated financial savings of more than $5.2 million to their organizations, according to initial results from a hospital-based...More >>
MD&M West Hosts a Premier MedTech Executive Summit Geared Toward Senior-level Professionals
MD&M West Hosts a Premier MedTech Executive Summit Geared Toward Senior-level Professionals
The Medical Design & Manufacturing Executive Summit will be held February 10-11, 2014 at the Anaheim Marriott, alongside the MD&D West Flagship Conference and Exposition. The world's largest medical design and...More >>
The Medical Design & Manufacturing Executive Summit will be held February 10-11, 2014 at the Anaheim Marriott, alongside the MD&D West Flagship Conference and Exposition. The world's largest medical design and...More >>
Hospice Comes to Times Square
Hospice Comes to Times Square
The estimated 950,000 people passing through Times Square in New York City every day will see messages affirming hospice care on the CBS Super Screen by 42nd Street throughout this holiday season. This is part of an...More >>
The estimated 950,000 people passing through Times Square in New York City every day will see messages affirming hospice care on the CBS Super Screen by 42nd Street throughout this holiday season. This is part of an...More >>
Third Clinical Study Confirms Treatment Guided By GeneSight Psychiatric Pharmacogenomics Test
Third Clinical Study Confirms Treatment Guided By GeneSight Psychiatric Pharmacogenomics Test
Assurex Health, a leading personalized medicine company, announced today the publication of a third clinical study providing evidence for the effectiveness of the GeneSight combinatorial pharmacogenomic test over the...More >>
Assurex Health, a leading personalized medicine company, announced today the publication of a third clinical study providing evidence for the effectiveness of the GeneSight combinatorial pharmacogenomic test over the...More >>
Healthcare Informatics Innovation Prize Accepting Submissions
Healthcare Informatics Innovation Prize Accepting Submissions
Two leading healthcare organizations have teamed up to honor pioneers in the application of clinical informatics solutions. To recognize the contributions of the physicians and nurses on the frontline of innovation, the...More >>
Two leading healthcare organizations have teamed up to honor pioneers in the application of clinical informatics solutions. To recognize the contributions of the physicians and nurses on the frontline of innovation, the...More >>
Renewal Laser Clinic Offers Astanza Trinity Laser Tattoo Removal as Minnesota's Only Ink Removal Dedicated Facility
Renewal Laser Clinic Offers Astanza Trinity Laser Tattoo Removal as Minnesota's Only Ink Removal Dedicated Facility
As the first laser tattoo removal focused clinic in Minneapolis, Renewal Laser Clinic provides a solution to tattoos of all ink colors with the Astanza Trinity laser system. Laser technician Nick Settich, CLS has performed...More >>
As the first laser tattoo removal focused clinic in Minneapolis, Renewal Laser Clinic provides a solution to tattoos of all ink colors with the Astanza Trinity laser system. Laser technician Nick Settich, CLS has performed...More >>
Quality Health Foundation Announces Call for Proposals
Quality Health Foundation Announces Call for Proposals
Quality Health Foundation (QHF)-the mission arm of Quality Health Strategies (QHS), a national not-for-profit organization committed to improving the quality of healthcare-announces a call for proposals for the 2014-2015...More >>
Quality Health Foundation (QHF)-the mission arm of Quality Health Strategies (QHS), a national not-for-profit organization committed to improving the quality of healthcare-announces a call for proposals for the 2014-2015...More >>
PMDA Approves Jarvik 2000 Heart in Japan
PMDA Approves Jarvik 2000 Heart in Japan
JARVIK HEART, Inc., a privately-held company that develops and manufactures cardiac assist devices, announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval to the Shonin (or...More >>
JARVIK HEART, Inc., a privately-held company that develops and manufactures cardiac assist devices, announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval to the Shonin (or...More >>
Achieve Beyond Pediatric Therapy Announces New Speech Therapy Clinic in Long Island
Achieve Beyond Pediatric Therapy Announces New Speech Therapy Clinic in Long Island
Achieve Beyond Pediatric Therapy and Autism Services, http://www.achievebeyondusa.com, is excited to announce the start of its new Speech Therapy Clinic in Melville, Long Island. Melville is conveniently located on the...More >>
Achieve Beyond Pediatric Therapy and Autism Services, http://www.achievebeyondusa.com, is excited to announce the start of its new Speech Therapy Clinic in Melville, Long Island. Melville is conveniently located on the...More >>
Clinical Care Options® to Deliver Presentation at 2013 American Society of Hematology Annual Meeting
Clinical Care Options® to Deliver Presentation at 2013 American Society of Hematology Annual Meeting
Clinical Care Options (CCO), the leading provider of clinical educational content and technological learning platforms, along with its partners, the Annenberg Center for the Health Sciences and AXDEV Group, is proud to...More >>
Clinical Care Options (CCO), the leading provider of clinical educational content and technological learning platforms, along with its partners, the Annenberg Center for the Health Sciences and AXDEV Group, is proud to...More >>
Texas Children's Center for Preventive Cardiology is the only center in Texas offering multidisciplinary, specialized care for children at risk for acquired heart disease
Texas Children's Center for Preventive Cardiology is the only center in Texas offering multidisciplinary, specialized care for children at risk for acquired heart disease
Texas Children's Heart Center is proud to announce the opening of the Center for Preventive Cardiology, which is designed to medically manage the risk factors of acquired heart disease in children. The center is the...More >>
Texas Children's Heart Center is proud to announce the opening of the Center for Preventive Cardiology, which is designed to medically manage the risk factors of acquired heart disease in children. The center is the...More >>
Global and Chinese Monoclonal Antibody Industry Report 2013
Global and Chinese Monoclonal Antibody Industry Report 2013
Research and Markets (http://www.researchandmarkets.com/research/4pvg4q/global_and) has announced the addition of the "Global and Chinese Monoclonal Antibody Industry Report, 2013" report to their offering.More >>
Research and Markets (http://www.researchandmarkets.com/research/4pvg4q/global_and) has announced the addition of the "Global and Chinese Monoclonal Antibody Industry Report, 2013" report to their offering.More >>
Surveyed Oncologists Indicate that the Use of Biomarker Testing is Increasing Rapidly in Non-Small-Cell Lung Cancer in China and South Korea
Surveyed Oncologists Indicate that the Use of Biomarker Testing is Increasing Rapidly in Non-Small-Cell Lung Cancer in China and South Korea
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of non-small-cell lung cancer (NSCLC), biomarker testing is already...More >>
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of non-small-cell lung cancer (NSCLC), biomarker testing is already...More >>
Kaiser Permanente Wins Six Awards for Digital Excellence
Kaiser Permanente Wins Six Awards for Digital Excellence
Kaiser Permanente has received six prestigious awards recognizing its use of digital tools to engage consumers in managing their health care and to enable employees to deliver high quality care.More >>
Kaiser Permanente has received six prestigious awards recognizing its use of digital tools to engage consumers in managing their health care and to enable employees to deliver high quality care.More >>
Tracking Exercise as a Vital Sign Associated with Weight Loss and Better Glucose Control for Patients
Tracking Exercise as a Vital Sign Associated with Weight Loss and Better Glucose Control for Patients
Asking patients about their exercise habits was associated with weight loss in overweight patients and improved glucose control for patients with diabetes, according to a recently published study in the Journal of General...More >>
Asking patients about their exercise habits was associated with weight loss in overweight patients and improved glucose control for patients with diabetes, according to a recently published study in the Journal of General...More >>
Research Funded by The Leukemia & Lymphoma Society Among Highlights at Annual American Society of Hematology Meeting
Research Funded by The Leukemia & Lymphoma Society Among Highlights at Annual American Society of Hematology Meeting
Many researchers funded by The Leukemia & Lymphoma Society (LLS) will be among those presenting exciting new directions in blood cancer research at the 55th American Society of Hematology (ASH) Annual Meeting and...More >>
Many researchers funded by The Leukemia & Lymphoma Society (LLS) will be among those presenting exciting new directions in blood cancer research at the 55th American Society of Hematology (ASH) Annual Meeting and...More >>
Measles Still Threatens Health Security
Measles Still Threatens Health Security
Fifty years after the approval of an extremely effective vaccine against measles, one of the world's most contagious diseases, the virus still poses a threat to domestic and global health security.More >>
Fifty years after the approval of an extremely effective vaccine against measles, one of the world's most contagious diseases, the virus still poses a threat to domestic and global health security.More >>
Dr. Renu Razdan of Max Neeman International Appointed Vice Chairman, ACRO India
Dr. Renu Razdan of Max Neeman International Appointed Vice Chairman, ACRO India
The Association of Contract Research Organizations [ACRO] India has appointed Max Neeman's Chief Operating Officer, Dr. Renu Razdan as Vice Chairman. The appointment is effective immediately with key responsibility to...More >>
The Association of Contract Research Organizations [ACRO] India has appointed Max Neeman's Chief Operating Officer, Dr. Renu Razdan as Vice Chairman. The appointment is effective immediately with key responsibility to...More >>
Study Confirms Efficacy of Innovative Therapies' Quantum Negative Pressure Wound Therapy (NPWT) in Enhancing Wound Healing
Study Confirms Efficacy of Innovative Therapies' Quantum Negative Pressure Wound Therapy (NPWT) in Enhancing Wound Healing
In the first randomized, controlled study to compare the efficacy of NPWT with and without simultaneous irrigation, researchers found that NPWT with or without irrigation reduced the wound size at a far greater rate than...More >>
In the first randomized, controlled study to compare the efficacy of NPWT with and without simultaneous irrigation, researchers found that NPWT with or without irrigation reduced the wound size at a far greater rate than...More >>
Thorne Research, Dr. Mark Houston, and the Hypertension Institute Launch TruCardia® - a New Venture Targeting Cardiovascular Health
Thorne Research, Dr. Mark Houston, and the Hypertension Institute Launch TruCardia® - a New Venture Targeting Cardiovascular Health
Thorne Research, Inc., a leader in developing and manufacturing pure, high-quality nutritional supplements marketed through licensed healthcare practitioners, today announced that the company has partnered with Mark...More >>
Thorne Research, Inc., a leader in developing and manufacturing pure, high-quality nutritional supplements marketed through licensed healthcare practitioners, today announced that the company has partnered with Mark...More >>
Issels Integrative Immunotherapy
Issels Integrative Immunotherapy
In recent years there has been a shift in the understanding of cancer. Immunotherapy with vaccines has been emerging as the most promising direction towards a decisive improvement of treatment outcomes.More >>
In recent years there has been a shift in the understanding of cancer. Immunotherapy with vaccines has been emerging as the most promising direction towards a decisive improvement of treatment outcomes.More >>
Alzheimer's Drug Discovery Foundation Presents its 8th Annual Drug Discovery for Neurodegeneration Conference in February 2014
Alzheimer's Drug Discovery Foundation Presents its 8th Annual Drug Discovery for Neurodegeneration Conference in February 2014
The Alzheimer's Drug Discovery Foundation (ADDF) presents its annual winter conference, the 8th Annual Drug Discover for Neurodegeneration Conference: An Intensive Course on Translating Research into Drugs, taking...More >>
The Alzheimer's Drug Discovery Foundation (ADDF) presents its annual winter conference, the 8th Annual Drug Discover for Neurodegeneration Conference: An Intensive Course on Translating Research into Drugs, taking...More >>
Aspira Scientific Introduces Xeno-free rHSA Product at World Stem Cell Summit
Aspira Scientific Introduces Xeno-free rHSA Product at World Stem Cell Summit
Aspira Scientific, Inc., a research and development solutions provider for the chemical and biological sectors, today announces the official launch of its recombinant Human Serum Albumin (rHSA) product. Aspira...More >>
Aspira Scientific, Inc., a research and development solutions provider for the chemical and biological sectors, today announces the official launch of its recombinant Human Serum Albumin (rHSA) product. Aspira...More >>
The Food and Drug Law Institute To Honor Axelrad, Gibbs, Holcombe, Kingham
The Food and Drug Law Institute To Honor Axelrad, Gibbs, Holcombe, Kingham
The Food and Drug Law Institute will honor four outstanding food and drug law professionals with its annual Distinguished Service and Leadership Award: Jane Axelrad, Jeffrey Gibbs, Kay Holcombe and Richard Kingham.More >>
The Food and Drug Law Institute will honor four outstanding food and drug law professionals with its annual Distinguished Service and Leadership Award: Jane Axelrad, Jeffrey Gibbs, Kay Holcombe and Richard Kingham.More >>
Aprima Medical Software and DMEhub Announce Joint Partnership
Aprima Medical Software and DMEhub Announce Joint Partnership
Aprima Medical Software and DMEhub™ today announced a joint partnership, making DMEhub available to Aprima users. The newest version of DMEhub is seamlessly integrated and fully supports the Aprima EHR system. DMEhub for...More >>
Aprima Medical Software and DMEhub™ today announced a joint partnership, making DMEhub available to Aprima users. The newest version of DMEhub is seamlessly integrated and fully supports the Aprima EHR system. DMEhub for...More >>
Few pharma websites optimized for mobile, according to Manhattan Research's new ePharma Competitive Analysis Series
Few pharma websites optimized for mobile, according to Manhattan Research's new ePharma Competitive Analysis Series
With patients increasingly searching for medical information on their smartphones, surprisingly few websites for prescription pharmaceuticals are ready for them. Just 28 percent of the 160 pharma-owned websites reviewed in...More >>
With patients increasingly searching for medical information on their smartphones, surprisingly few websites for prescription pharmaceuticals are ready for them. Just 28 percent of the 160 pharma-owned websites reviewed in...More >>
Omnicell Expands its Unity Platform to Further Integrate Workflows
Omnicell Expands its Unity Platform to Further Integrate Workflows
Omnicell, Inc. (OMCL) will be exhibiting at the American Society of Health-System Pharmacists 2013 Mid-Year Meeting in Orlando. Omnicell's 2013 theme, "How Far Can You Reach?" reflects the company's solutions...More >>
Omnicell, Inc. (OMCL) will be exhibiting at the American Society of Health-System Pharmacists 2013 Mid-Year Meeting in Orlando. Omnicell's 2013 theme, "How Far Can You Reach?" reflects the company's solutions...More >>
Urologists Applaud Senators for Their Strong Support of Patient Access to Coordinated Care
Urologists Applaud Senators for Their Strong Support of Patient Access to Coordinated Care
Today, the American Association of Clinical Urologists (AACU), American Urological Association (AUA) and LUGPA applauded the Physician's Caucus of the United States Senate who joined their physician colleagues in the...More >>
Today, the American Association of Clinical Urologists (AACU), American Urological Association (AUA) and LUGPA applauded the Physician's Caucus of the United States Senate who joined their physician colleagues in the...More >>
ViveBio's Transformational Specimen Storage and Transportation Device, ViveST™, Featured in Presentation at HEP DART 2013
ViveBio's Transformational Specimen Storage and Transportation Device, ViveST™, Featured in Presentation at HEP DART 2013
ViveBio, LLC announced today that ViveST™, its transformational specimen storage and transportation device, will be featured in a presentation at the 2013 HEP DART conference being held December 8-12, 2013 in Hawaii. The...More >>
ViveBio, LLC announced today that ViveST™, its transformational specimen storage and transportation device, will be featured in a presentation at the 2013 HEP DART conference being held December 8-12, 2013 in Hawaii. The...More >>
HCCS Releases New Health Plan Compliance Online Training Course
HCCS Releases New Health Plan Compliance Online Training Course
New Course Focuses on Reducing Fraud, Waste and AbuseMore >>
New Course Focuses on Reducing Fraud, Waste and AbuseMore >>
ZocDoc Releases 2013 U.S. Health Checkup, Revealing This Year's Top Patient Trends
ZocDoc Releases 2013 U.S. Health Checkup, Revealing This Year's Top Patient Trends
ZocDoc, a service that helps patients receive faster access to care and optimizes doctors' schedules, today released its second annual U.S. Health Checkup. Millions of patients each month use ZocDoc.com or the free...More >>
ZocDoc, a service that helps patients receive faster access to care and optimizes doctors' schedules, today released its second annual U.S. Health Checkup. Millions of patients each month use ZocDoc.com or the free...More >>
XYMOGEN Launches i5 Energize To Support Gastrointestinal Health And Energy
XYMOGEN Launches i5 Energize To Support Gastrointestinal Health And Energy
Orlando-based health-sciences company XYMOGEN announced that i5 Energize, the latest formula in the company's line of detoxifying biotransformation shake mixes, is now available.More >>
Orlando-based health-sciences company XYMOGEN announced that i5 Energize, the latest formula in the company's line of detoxifying biotransformation shake mixes, is now available.More >>
The Leukemia & Lymphoma Society Honors FDA Associate Director, Gregory Reaman, M.D. with the Return of Child Award
The Leukemia & Lymphoma Society Honors FDA Associate Director, Gregory Reaman, M.D. with the Return of Child Award
The Leukemia & Lymphoma Society (LLS) today is pleased to announce Gregory Reaman, M.D., associate director for oncology sciences with the office of hematology and oncology products of the U.S. Food and Drug...More >>
The Leukemia & Lymphoma Society (LLS) today is pleased to announce Gregory Reaman, M.D., associate director for oncology sciences with the office of hematology and oncology products of the U.S. Food and Drug...More >>
DebMed® Announces Major Enhancement to its Electronic Hand Hygiene Monitoring System
DebMed® Announces Major Enhancement to its Electronic Hand Hygiene Monitoring System
DebMed®, creator of the award-winning, world's first electronic hand hygiene compliance monitoring system based on the World Health Organization's (WHO's) Five Moments for Hand Hygiene, announced today a...More >>
DebMed®, creator of the award-winning, world's first electronic hand hygiene compliance monitoring system based on the World Health Organization's (WHO's) Five Moments for Hand Hygiene, announced today a...More >>
Howard Leonhardt of Leonhardt Ventures to Present at World Stem Cell Summit December 6th
Howard Leonhardt of Leonhardt Ventures to Present at World Stem Cell Summit December 6th
Howard Leonhardt of Leonhardt Ventures and the Cal-X Stars Innovation and Business Accelerator team will present at the 2013 World Stem Cell Summit on Friday, December 6, 2013 at the Manchester Grand Hyatt in San Diego in...More >>
Howard Leonhardt of Leonhardt Ventures and the Cal-X Stars Innovation and Business Accelerator team will present at the 2013 World Stem Cell Summit on Friday, December 6, 2013 at the Manchester Grand Hyatt in San Diego in...More >>
MO BIO Laboratories, Inc. becomes ISO 9001:2008 certified
MO BIO Laboratories, Inc. becomes ISO 9001:2008 certified
MO BIO Laboratories, Inc., the leader in soil, microbial, stool, and plant nucleic acid purification, has been independently audited and is now ISO 9001:2008 certified for the design and manufacture of reagents and kits...More >>
MO BIO Laboratories, Inc., the leader in soil, microbial, stool, and plant nucleic acid purification, has been independently audited and is now ISO 9001:2008 certified for the design and manufacture of reagents and kits...More >>
Hovione: New Inhalation Capsule Filling Machine Fills Market Gap
Hovione: New Inhalation Capsule Filling Machine Fills Market Gap
Hovione announced today the expansion of its inhalation drug product development services with the introduction of a high precision MG2 FlexaLAB capsule filling machine. This investment is in response to market demand for...More >>
Hovione announced today the expansion of its inhalation drug product development services with the introduction of a high precision MG2 FlexaLAB capsule filling machine. This investment is in response to market demand for...More >>

PR Newswire IndexMore>>
Entertainment News Releases via PRNewswire
Entertainment
Entertainment News Releases via PRNewswire
Travel
Travel News Releases via PRNewswire
Political Campaigns
Political Campaigns News Releases via PRNewswire
Medicine & Pharmaceuticals
Medicine & Pharmaceuticals News Releases via PRNewswire
Film & Motion Picture News Releases via PRNewswire
Film & Motion Picture
Film & Motion Picture News Releases via PRNewswire
Economic News and Analysis
Economic News Releases via PRNewswire
Computer Software
Computer Software News Releases via PRNewswire
Computer Networks
Computer Networks News Releases via PRNewswire
Computer Hardware
Computer Hardware News Releases via PRNewswire
Biotech News Releases via PRNewswire
Biotechnology
Biotechnology News Releases via PRNewswire

ABC6 ExtraMore>>
Be Our Guest
Be Our Guest
Click here to get 1/2 off gift certificates!More >>
Get Half-Priced Gift Certificates!More >>
Contests
Contests
Click here to see our ABC6 Contests page!More >>
Click here to see our ABC6 Contests page!More >>
Lottery
Lottery
Is today your lucky day? Click here to get the daily numbers.More >>
Horoscopes
Horoscopes
Daily horoscopes for life, love, work and more!More >>
Green Living
Green Living
Find latest environmental news, tips and information for staying green.More >>
Pets
Pets
Learn more tips for caring for, grooming and training your favorite pet.More >>

Medicine & Pharmaceuticals - ABC6 - Providence, RI and New Bedford, MA News, Weather

HeadlinesMore>>